Leveraged & Inverse Channel Traders Can Look to Biotech ETFs to For a Potential Virus Cure By Ben HernandezMay 19, 2020
Leveraged & Inverse Channel Consider These 2 Leveraged Biotech ETFs to Ride The M&A Trend By Ian YoungDecember 13, 2019
Leveraged & Inverse Channel 5 Leveraged ETFs With Biggest 1-Month Fund Flows By Ben HernandezMay 22, 2019
Leveraged & Inverse Channel Stock ETFs Outpace Bond ETF Interest By $18B April By Ian YoungMay 6, 2019
Leveraged & Inverse Channel 5 Best-Performing Leveraged ETFs Year-to-Date By Ben HernandezMarch 29, 2019
Leveraged & Inverse Channel Big Biopharma Mergers Could Fuel These ETFs in 2019 By Ben HernandezJanuary 10, 2019
Leveraged & Inverse Channel Biotech ETFs Hoping This Post-Election Trend Doesn’t Repeat By Brenton GarenNovember 8, 2018
Leveraged & Inverse Channel After a Rough October, Leveraged Biotech ETF Looks to Bounce Back By Brenton GarenNovember 6, 2018
